|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||N/A - N/A|
|52-week range||undefined - undefined|
|PE ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y target est||N/A|
Britain's Destiny Pharma , which is developing drugs to target antibiotic-resistant bacterial infections, has raised 15.3 million pounds by listing shares on London's AIM market. The proceeds will be used ...